Malaysia buys additional 12.2 million doses of Pfizer-BioNTech COVID-19 vaccine
- Country:
- Malaysia
Malaysia on Monday signed a deal to buy an additional 12.2 million doses of a COVID-19 vaccine manufactured by U.S. and German drugmakers Pfizer and BioNTech, the health ministry said in a statement.
The deal brings the total amount of the Pfizer vaccines procured by Malaysia to 25 million doses, enough to cover 39% of its population, the ministry said.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
Advertisement
ALSO READ
Health News Roundup: Pfizer RSV shot meets goals in trial of high-risk adults under age 60; Cuba says drug use on the rise, especially among youth and more
Health News Roundup: GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology; Gilead posts quarterly loss, revenue rises 5% and more
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Google News